Global mammalian transient protein market revenues are projected to surpass US$ 540 million in 2020, according to a new study by Future Market Insights (FMI). The report also states that, innovations in automation and recombinant proteins will support market developments, however, prohibitive costs and complexity to maintain media purity remain challenges.
The mammalian transient protein expression market has reflected steady growth on the back of growing demand from the biomedicine sector. Efforts into vaccine development continue to create possibilities for new opportunities.
A recent market study by Future Market Insights on the mammalian transient protein expression market opines that the market will reach US$ 540 Mn valuation in 2020.
In recent years, the mammalian transient protein expression market has displayed strong growth with rising interest in terms of academics and researchers in the bio-medicine sector. These factors influence market developments through the forecast period.
Advancements in Genetic Research Creates Opportunities
Innovations in the field of genetic research have played a key role in the development mammalian transient protein expression as an efficient process. Research on the characteristics of animal cells has gained increasing importance in the zoology domain. Academic applications on genetic mutations in animals will further lead to gains in this discipline.
Market players are leveraging the growing investments into the field of genetic research and have displayed interest towards cultures of animal cells, in addition to the development of therapeutic proteins. Studies on genetic expression for plants and animals, and methods used for genetic expression in progeny continue to aid development.
Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-12807
Key Takeaways on Mammalian Transient Protein Expression Market
- The size of the mammalian transient protein expression market is estimated to reach approximately US$ 540 Mn by the end of 2020, with antibody and therapeutic protein production applications being the primary factors driving growth in the industry.
- Biopharmaceutical companies will remain prominent end-users of mammalian transient protein expression, while CROs are also likely to reflect steady growth on the back of biologics and drug development endeavours.
- Chinese hamster ovary cells in terms of cell lines reflect relatively higher demand, owing to applications in academic and research uses, accounting for ~70% of market share by 2030.
- North America followed by Europe are leading markets for mammalian transient protein expression, access to cutting edge healthcare technologies, and the presence of leading market players.
“A significant increase in R&D activities biopharmaceutical, pharmaceutical, and biotechnology market participants to develop and manufacture advanced biologics including monoclonal antibodies, vaccines, and therapeutic proteins is driving demand for mammalian transient protein expression. Also, investments into drug development is important to propel long-term growth,” said a lead analyst from FMI.
Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-12807
Covid-19 Impact on Mammalian Transient Protein Expression Market
The Impact of the covid-19 pandemic on the mammalian transient protein expression market has largely been negative. Strict lockdown and social distancing regulations has resulted in delayed projects in research and biomedicine applications.
Also, market players have witnessed lower sales and revenue during the crisis period arising from supply chain disruptions, and shortage of adequate manpower. On the other hand, potential for applications in vaccine development is likely to provide opportunities for short-term growth, moderately mitigating loss during this period.
Who is Winning?
In its latest report, Future Market Insights has provided details on key business strategies that are gaining importance in the mammalian transient protein expression market. Market leaders in the industry have been pushing on the expansion of their portfolios with offerings associated to antibody development and gene coding. Also, strategic collaborations are gaining ground in the sector.
Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/12807
Merck KgaA, Thermo Fisher Scientific, Agilent Technologies Inc., Lonza, Mirus Bio Inc., Takara Bio Inc., Qiagen N.V., and Bio-Rad Laboratories Inc., are some of the key companies operating in the mammalian transient protein expression market.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success.